Liminatus Pharma Class A Common Stock Statistics Share Statistics Liminatus Pharma Class A Common Stock has 27.06M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 27.06M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares 9,385 FTD / Avg. Volume 1.59%
Short Selling Information The latest short interest is 202.59K, so 0% of the outstanding
shares have been sold short.
Short Interest 202.59K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.24 and the forward
PE ratio is null.
Liminatus Pharma Class A Common Stock's PEG ratio is
0.
PE Ratio -1.24 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0 P/FCF Ratio 0 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Liminatus Pharma Class A Common Stock.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.09,
with a Debt / Equity ratio of -0.32.
Current Ratio 0.09 Quick Ratio 0.09 Debt / Equity -0.32 Debt / EBITDA -12.65K Debt / FCF -1.65 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-135 Employee Count 3 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 18.84K Effective Tax Rate -4652.1%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 0.52, so Liminatus Pharma Class A Common Stock's
price volatility has been higher than the market average.
Beta 0.52 52-Week Price Change n/a 50-Day Moving Average 10.37 200-Day Moving Average n/a Relative Strength Index (RSI) 38.92 Average Volume (20 Days) 591,340
Income Statement
Revenue n/a Gross Profit n/a Operating Income -405 Net Income -405 EBITDA -405 EBIT n/a Earnings Per Share (EPS) -4.05
Full Income Statement Balance Sheet The company has 804.54K in cash and 5.12M in
debt, giving a net cash position of -4.32M.
Cash & Cash Equivalents 804.54K Total Debt 5.12M Net Cash -4.32M Retained Earnings -17.52M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -3.11M
and capital expenditures 0, giving a free cash flow of -3.11M.
Operating Cash Flow -3.11M Capital Expenditures n/a Free Cash Flow -3.11M FCF Per Share -31064.6
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
